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Abstract
LOCALIZATION OF GFP-RAD52 IN STABLE HUMAN CELL LINES.
Rachel Lovins, Yilun Liu, and Nancy Maizels. Departments of MB&B and
Genetics, Yale University School of Medicine, New Haven CT.

We have examined the expression and localization of Rad52 in human cells. Rad52
is a protein shown to be essential to recombination and repair in yeast. Biochemical studies
have demonstrated that Rad52 has similar in vitro functions in mammals, but its in vivo role
in mammals is unclear.
In our experiments we analyzed localization of Rad52 tagged with Green
Fluorescent Protein (GFP). We used an LXSN retroviral vector containing GFP-Rad52 to
infect a variety of human cell lines including fibroblasts and lymphocytes. Infected cells
were selected with G418. Fluorescent microscopy showed that HT1080, Akata and 50% of
the HeLa cells expressing GFP-Rad52 had the signal localized to the nucleus. In these cells
the GFP signal was either concentrated in the nucleoli or excluded from it. These results
were consistent with previous studies using mouse cells. GFP-Rad52 expression in Raji
(EBV-transformed pre-B cells) was very weak making it difficult to evaluate. The GFP
signal in Saos-2 (cells lacking the tumor suppressor gene p53) and many of the HeLa cells
was localized to the cytoplasm and excluded from the nucleus.
We conclude that in human cells GFP-Rad52 localizes mainly to the nucleus and
exhibits the patterns of either exclusion from the nucleoli or concentration in the nucleoli
that has been demonstrated in murine cells. The cause of the high degree of cytoplasmic
non-nuclear distribution in HeLa and Saos-2 cells is unknown but may be related to cell
death and deserves further study.

Table of Contents

1. Introduction.1
1.1 Anticipated Results.6
2. Statement of Purpose.7
3. Materials and Methods.7
3.1 Cell Culture.7
3.2 Retroviral construct.8
3.3 Infection and creation of stable cell lines.9
3.4 Visualization and Microscopy.10
4. Results. 10
4.1 Infection of amphoteric cell line.10
4.2 Selection of adherent cells.12
4.3 Expression and Localization of GFP-Rad52 in adherent cells.12
4.4 Selection of non-adherent cells.16
4.5 Expression and Localization of GFP-Rad52 in non-adherent cells.16
5. Discussion.17
5.1 Efficiency of Transduction.17
5.2 Localization of Signal.18
5.3 Conclusions.19
6. References

20

1. Introduction
All cells must be able to repair breaks in their DNA in order to survive.
Double strand DNA breaks occur during a variety of processes including meiotic division,
V(D)J recombination in lymphocytes, and as a result of radiation and chemically induced
damage. Two main pathways have been identified for repairing broken double strand DNA
in eukaryotic cells: end to end rejoining using Ku protein, and homologous recombination
(1). Homologous recombination in eukaryotic cells has been shown to involve several
proteins including Rad52.
Rad52 is a member of the Rad52 epistasis group, a family of genes involved in
DNA repair which includes Rad5Q-55, Rad57, Rad59, MRE1J, and XRS2 (2, 3) (4, 5).
The Rad.52 gene is located on chromosome 12p 12.2-p 13 in humans (2)) and the protein it
encodes is 418 amino acids in length. The protein contains several domains of defined
function including a DNA binding domain at the N terminus, domains that allow interaction
with Rad51 and Replication Binding Protein (RPA), and a self-association domain (6) (Fig.
1).

Fig. 1 Human Rad52 and its interaction domains

Rad52/DNAj |Rad52/Rad52

Rad52/RPA

Rad52/Rad51

"1

Fig. ! - The human Rad52 protein and its known protein interaction domains including self
(Rad52/Rad52), DNA (Rad52/DNA), RPA (Rad52/RPA) and Rad51 (Rad52/Rad51) binding
regions.
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Recombination involves genetic exchange between DNA sequences. In meiosis,
(exchange between homologous DNA sequences on two copies of the same chromosome),
this allows for the distribution of separate alleles to the next generation. Recombination can
also occur in a site-specific fashion when foreign DNA is either insertedinto or excised
from genomic DNA (Fig. 2).

Fig 2.

Homologous Recombination

Strand exchange: These types of reactions are promoted by RecA and involve
Rad52, Rad5 1 and RPA in yeast. On the left is an example of non-reciprocal strand exchange
between single stranded and double stranded DNA. On the right is an example of reciprocal
strand exchange between duplex DNA as occurs in meiosis.

Rad51 is the eukaryotic homologue of RdcA, a critical prokaryotic recombination
protein. Working in conceit with other proteins, Rad51 is also integral to the DNA
recombination/repair pathway in yeast (3, 7). Yeast with a null mutation in Rad51
accumulate double stranded breaks during meiosis (8).
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It is Rad52, however, which is the most critical recombination repair protein in S.
cerevisiae (5, 9). Rad52 is required for mitotic recombination in yeast and Rad52 mutants

are unable to reproduce, are hypersensitive to ionizing radiation and have deficiencies in
homologous and ribosomal DNA (rDNA) recombination (5, 10, 11). Biochemical studies
have shown that Rad52 binds to both single stranded and double stranded DNA and it has
been known to synergize with Rad51 in strand transfer reactions (1,9, 12-14). The
probable role of Rad52 in homologous recombination during meiosis in germ cells may
explain the high levels of the protein that have been found in the testes of chicken and mice
(2).
Rad52 has also been shown to be necessary for Replication Protein A (RPA)-single
strand DNA annealing in some conditions (15). During strand exchange RPA appears to
compete with Rad51 for DNA interaction sites. Rad52 appears to inhibit RPA/DNA
binding, allowing Rad51 to bind to the DNA (16, 17). This might explain why Rad52 acts
as a catalyst in Rad51 reactions when Rad51 is at subsaturating concentrations (18). In
yeast therefore, Rad52, Rad51 and RPA are all necessary to stimulate strand exchange.
In addition to associations through the known interaction domains, Rad52 is most
likely also associated with other proteins involved with DNA repair. BRCA1 and BRCA2
have been shown to interact with Rad51 and may be additional cofactors in Rad51/Rad52
mediated double strand break repair (19-21). Since Rad51 is known to associate with
Rad52 and BRCA1 and BRCA2, it has raised the possibility that Rad52 is involved in the
development of early onset breast cancer, although this is controversial (22, 23).
There is a high degree of conservation of Rad52 across species (Table 1). The
conservation between yeast and mammalian Rad52 proteins is mainly confined to the Nterminal DNA binding region. The Rad52/Rad51 and Rad52/RPA interaction sites,
however, appear not to be highly conserved between yeast and mammals. There is no
homology to the Rad51 interacting domain of human Rad52 in yeast (24). In addition, the
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RPA binding region of human Rad52 has very limited homology between species and only
~7% identity between yeast and human (6). Since Rad52 is known to interact with Rad51
and RPA in both yeast and mammals, the reason for the lack of conservation in these
domains remains unclear at this time. It may be due to differences in the primary structure
of RPA and Rad51 across species.

Table 1
Comparison of Human Rad52 Amino Acid Composition With Other Organisms

Overall length

Gaps

Similarity
(%)

Mouse
Chicken

431
432

Identity
(%)

9

80.5

71.7

7

73.0

57.8

S. cerevisiae

501

12

51.0

30.8

K. lactice

438

11

51.8

30.5

S. Pombe

All

8

49.6

30.7

Percentage similarity and identity of amino acids of the Rad52 of several organisms to the human
protein. There is a great deal of conservation between murine and human Rad52. Identity between
species is mainly in the N-terminus region (2).

In contrast to yeast, genetic analysis in mammals has shown that Rad52 knockout
mice, while demonstrating slightly reduced homologous recombination, do not show
increased sensitivity to ionizing radiation or chemically induced double strand breaks, or
any impairment in viability, fertility or immune function (4). This is especially surprising
given that in vitro studies have strongly suggested that Rad52 plays an important role in
DNA repair by synergizing with Rad51 (15, 18).
Electron microscopic studies have shown that human Rad52 binds to single strand
ends of linear DNA and forms molecular bridges in large protein networks. Thus, both
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yeast and human Rad52 can facilitate the formation of molecular complexes and the
recruitment of Rad51. This suggests several roles for Rad52 in vivo, including protecting
free DNA ends from exonuclease digestion, recruiting other proteins such as Rad51 and
enhancing homologous pairing (1,25). If human and yeast Rad52 have the same function
in vitro, why do they have such different effects in vivol

It is of interest to determine whether Rad52 actually does have a different function in
mammalian cells than in yeast cells, or whether the apparent lack of effect of the murine
Rad52 deletion reflects the ability of mammals to rely on alternate methods of DNA repair.
There is some evidence that in S. cerevisiae, Rad55, Rad57 and Rad59 have overlapping
function with Rad52 since over-expression of Rad52 can suppress mutations found in
Rad55, Rad57 and Rad59 mutants (26). Alternatively, the Ku mediated pathway may
compensate for the absence of Rad52 in mammalian cells.
Despite the lack of the expected phenotype in mice with a mutation in Rad52, there
are several studies that have pointed to a clear role for Rad52 in DNA repair/recombination
in mammalian cells. Over-expression of human Rad52 has been reported to confer
enhanced resistance to gamma-rays and induce homologous intra-chromosomal
recombination in monkey cells (27). Yeast Rad52 introduced into human HT1080 cells
caused the cells to have a markedly increased frequency of inter-plasmid homologous DNA
recombination (28). In addition it has recently been observed that expression of Rad52
tagged with green fluorescent protein (GFP-Rad52) in murine cells confers greater survival
after damage with ionizing radiation. (Liu and Maizels, submitted).
To investigate the involvement of mammalian Rad52 in DNA repair in vivo, Yilun
Liu in the laboratory of Nancy Maizels at Yale University School of Medicine has studied
the localization of Rad52 in murine spleen cells during the cell cycle and after induction of
DNA damage by ionizing radiation. By imaging cells expressing GFP-Rad52, Liu
demonstrated that the protein was distributed throughout the nucleus but typically excluded
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from the nucleoli during G1 phase; highly concentrated in the nucleoli during S phase
(during rDNA synthesis); and distributed throughout the cell during M phase (when the
nuclear envelope was not intact) (29). Rad52 has been shown to participate in rDNA
recombination in yeast (30, 31). This offers an explanation as to why Rad52 localizes in
the nucleolus during S-phase in mice. Although it is likely that it is involved in the same
rDNA process in mammals, this has not been conclusively shown.
Localization of GFP-Rad52 has also been studied in murine cells treated with
ionizing radiation to cause DNA double strand breaks. Following treatment with 5 Gy,
GFP-Rad52 was shown to be localized to multiple foci within the nucleus. Rad50, a DNA
repair protein known to be essential to mammalian viability (32), also relocalized to form
foci and colocalized with GFP-Rad52 (29).
In vitro studies have shown that human Rad51 binds directly to Rad52, as discussed
above. In vivo experiments have shown that murine Rad52 also colocalizes with murine
Rad51 after radiation induced DNA damage, further strengthening the association of Rad52
with the DNA repair complex in mammals (Liu and Maizels, submitted). The foci may
correspond to sites of active DNA repair.

1.1 Anticipated Results
Missing from the literature to date are in vivo studies of Rad52 localization and
response to double strand DNA damage in human cells. In addition, further studies are
needed to clarify the relationship of Rad52, RPA, BRCA1 and BRCA2 in human cells.
Because of the high degree of homology between mouse and
human Rad52, it is expected that Rad52 will function in a similar fashion in human and
mouse cells. It is possible, however, that different human cell lines may rely on Rad52 to
varying degrees. For example, developing lymphocytes undergo V(D)J rearrangement to
generate specific antibodies. This occurs in the thymus and spleen and elevated Rad52
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levels have been found in murine thymus and spleen tissues (4). Therefore, Raji and Akata
(EBV-transformed B cells) may show enhanced Rad52 activity.
One especially critical protein in mammalian cells is p53. Sometimes referred to as
“the guardian of the genome”, p53 normally induces cell cycle arrest or apoptosis when
DNA damage needs to be repaired. Cells lacking this safeguard accumulate DNA damage,
and it is therefore not surprising that p53 mutation contributes to many types of cancers.
As p53 mutant cells lack the molecular machinery to recognize some of their own double
strand breaks, it is possible that they may exhibit decreased recruitment or expression of
Rad52.

2. Statement of Purpose

We sill study the localization of Rad52 in human cells by generating stable human
cell lines which express GFP-Rad52 via retroviral transduction.

3. Materials and Methods

3.1 Cell Culture

All cells were obtained from previously frozen cells lines or split from existing cell
lines maintained in the laboratories of Dr. Nancy Maizels and Dr. Alan Weiner at Yale
University School of Medicine. Adherent cells including the murine cell lines PA317 and
PE501, and human cell lines HT1080, HeLa, and Saos-2 (p53 mutant) were cultured in
DMEM (Gibco), 10% fetal bovine serum, 100 U/ml penicillin and 100 (ig/ml streptomycin.
Non-adherent cells including the human B cell lines Raji and Akata were cultured in RPMI
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1640 (Gibco), 10% fetal bovine serum, 100 U/ml penicillin, 100 jig/ml streptomycin and 10
pM B-mercaptoethanol. All cells were incubated at 37°C in 5% C02.

3.2 Retroviral Construct

To facilitate visualization of Rad52, we used a construct in which-murine Rad52 was
tagged with Green Fluorescent Protein (GFP) using a gene derived originally from the
jellyfish Aequorea victoria (33). The construct was generated and generously provided by
Yilun Liu in the laboratory of Dr. Nancy Maizels, Yale University School of Medicine (Fig.
3). The cloning and generation of this construct have been described previously (29). The
GFP-Rad52 fusion gene was carried in the retroviral vector LXSN. The backbone of the
vector was derived from the murine retroviruses MoMLV and MoMSV (34). The vector
carries the gene for G418 (neomycin) resistance as a positive selection marker and was
propagated in the murine ecotropic retrovirus packaging cell line, PE501. This virusproducing cell line (referred to as PE501/GFP-Rad52) was maintained by culture in
DMEM with 1 mg/ml of G418 for selection.

Fig. 3

LXSN

Fig. 3

LXSN Retroviral Vector For GFP-Rad52

LTR

GFP

Ra'd52|

The LXSN retroviral vector containing GFP-Rad52.

for neomycin (G418) resistance (yellow box).

NEO

LTR

This construct contains a gene

The GFP is attached to the N-terminus of

Rad52. Arrows indicate promoters and direction of transcription. Indicated genetic regions
are: L.TR - long terminal repeat. GFP - Green Fluorescent Protein. SV - Simian Virus
40. Neo - gene for neomycin resistance.
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3.3 Infection and creation of stable cell lines.

Infection of adherent cells-

To create an amphoteric retroviral stock, when PE501/GFP-Rad52 cells were
approximately 80% confluent, excess medium was removed, 8 ml of fresh medium was
added, and culture continued for one hour. Retrovirus was separated from the cells by
filtration through a 0.45 micron filter. For infection of PA317 cells (the amphoteric
packaging line), excess medium was removed from an actively proliferating culture of
PA317 cells and replaced with a cocktail of 40% retrovirus stock, 40% DMEM with 8
jig/ml polybrene (Sigma), and 20% fresh medium. This procedure was repeated every hour
for a total of three times and the PA317 cells were then left to incubate for 24 hours. The
cells were then selected by culture in DMEM containing 1 mg/ml G418. The selection
medium was changed every day for four days to remove dead cells, and then approximately
every other day for the duration of the experiment. Fourteen days after infection, retrovirus
from the infected PA317 cells was harvested through filtration and used to infect the human
adherent cells in the same manner described above. Filtration to separate virus from host
was essential: omission of this step in one set of experiments resulted in mixed cell
populations.

Infection of Non-Adherent Cells

The non-adherent, B lymphocyte lines Raji and Akata were infected by co¬
incubation with amphoteric packaging cell line PA317/GFP-Rad52 as follows. Medium
from a flask of PA317/GFP-Rad52 cells was removed and replaced with 30% non-adherent
cells in suspension at a concentration of 106 cells/ml, 40% RPMI containing 8 pg/ml
polybrene, and 30% fresh medium. After 24 hours, the non-adherent cells were removed by
aspiration, spun down resuspended in RPMI. The infection process was then repeated for a
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total retrovirus exposure time of 48 hours. Non-adherent cells were then removed,
centrifuged and resuspended in a separate flask containing 1.5 mg/ml G418 in RPMI. The
selection conditions were verified by examining parallel Raji and Akata cell control cultures
for cell death. On day five the G418 resistant cells were expanded by transfer into larger
flasks and feeding and selection continued. This method produced transductants of Akata
but not Raji despite numerous attempts.

3.4 Visualization and Microscopy

To visualize GFP-Rad52 in non-adherent cells, the cells were harvested by
centrifugation, resuspended in PBS, then centrifuged onto glass slides at 800 rpm for 4
minutes in a Cytospin 3. To visualize the GFP signal in adherent cells, the cells were grown
on tissue culture chamber slides (Nalge Nunc International) and then washed once with
PBS before observation under the microscope. Both types of cells were then examined
under fluoroscopic magnification. Cell structure was also visualized using transmitted light
when possible.

4. Results

4.1 Infection of amphoteric cell line

Although the viral construct containing GFP-Rad52 (Fig. 3) had been successfully
used to infect several types of murine cells, it had never been introduced into human cells.
We therefore used the ecotropic, murine PE501/GFP-Rad52 retrovirus packaging cell line
to infect PA317, a packaging cell line which produces virus capable of infecting human
cells. The infection was carried out by placing filtered virus-containing medium from the
ecotropic cell line into flasks containing PA317. After 24 hours the newly infected cells
were selected in RPMI medium containing G418 to select for transformed cells. After an

additional 24 hours, many of the cells in the newly infected flasks were dead, and within
several days it was apparent that small colonies were thriving. By day 5 the cells had
completely recovered and were maintained in their selection medium. To verify that the
packaging lines expressed GFP-Rad52, PE501/GFP-Rad52 and PE317/GFP-Rad52 were
grown on tissue chamber slides and imaged under fluorescent microscopy. The GFPRad52 was localized to the nuclei in all cells, either concentrated in or excluded from the
nucleoli (Fig 4). These results are identical to those previously described in studies of
GFP~Rad52 in murine fibroblasts (29).

Fig. 4

Expression of GFP-Rad52 in Murine Fibroblasts

Fig. 4 -Localization of GFP-Rad52 in PE501/GFP-Rad52 cells. A - Examples of cells showing nuclear
localization with exclusion from the nucleoli, B - A group of cells showing nuclear localization with
concentration in the nucleoli.

4.2 Infection and selection of adherent human cells
After a stable line of PA317/GFP-Rad52 cells was produced, the human adherent
cells were infected. Adherent cells chosen for infection included the fibroblast derived cell
lines HeLa and HT1080, and the p53 mutant cell line Saos-2. By day 3 of selection, many
of the Saos-2 and HT1080 cells were dead, but the HeLa cells remained vigorous and
confluent. The survival of HeLa cells was measured as function of G418 concentration.
This showed that HeLa cells required a G418 concentration of 1.0 mg/ml for selection,
twice that of the other human adherent cells.
Selection medium was changed every 1-2 days. By day 9 all the adherent cells were
fully recovered and had reached confluence. For observation, cells were split 1:20 onto
tissue culture chamber slides. When -70-90% confluent they were imaged under
fluorescent and transmitted light.

4.3 Expression and localization of GFP-Rad52 in adherent cells

HT1080

The fibroblast cell line HT1080 showed strong GFP signals in many cells. The
signal was localized mainly to the nucleus and often concentrated in the nucleolus. Some
cells showed the signal localized to the nucleus but excluded from the nucleoli (Fig. 5). The
localization of GFP-Rad52 within the cells was confirmed by phase imaging (Fig. 5).
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Fig. 5

Expression of GFP-Rad52 in HT1080 Ceils

Fig. 5 - Phase and fluoroscopic images of HT1080 cells expressing GFP-Rad52. The
protein is localized to the nucleus and concentrated in the nucleoli. Left, transmitted light;
Center, GFP-Rad52; Right, merged image.

HeLa

In about 50 % of cells which expressed GFP-Rad52, the protein was localized to the
nucleus. In these HeLa cells, the protein was often concentrated in the nucleolus (Fig. 6).
A possibly significant finding in this cell line was that the other 50% of cells expressing
GFP-Rad52 showed cytoplasmic localization with exclusion from the nucleus (Fig. 6).
These cells, however, were round and in overly confluent areas suggesting that they were
end-stage or dying.

Fig. 6

Expression of GFP-Rad52 in HeLa Cells

Fig. 6 Phase and fluoroscopic images of GFP-Rad52 expression in HeLa cells. A - Cells
showing nucleolar localization. B Cells showing nuclear localization. C - Cells showing
cytoplasmic localization.
merged image.

For A and B: Left, transmitted light; Center. GFP-Rad52; Right,

Saos-2

The GFP-Rad52 signal in Saos-2 cells was much weaker than in the other adherent
cell lines and was expressed in very few cells (-1/500). It faded quickly under prolonged
fluoroscopic exposure making the capturing of images difficult. In most cells, GFP-Rad52
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was localized to the cytoplasm (Fig. 7). No Saos-2 cells demonstrated a clearly defined
nuclear or nucleolar localization.

Fig. 7

Expression of GFP-Rad52 in Saos-2 cells

Fig. 7 Patterns of GFP-Rad52 expression in Saos-2 cells. A - An example of one cell with
GFP-Rad52 localized to the cytoplasm. B - Three distinct cells showing the identical pattern.
Left, transmitted light; Center, GFP-Rad52; Right, merged image.

4.4 Selection of non-adherent human cells

The EBV transformed B cell lines Raji and Akata were infected numerous times
under several conditions. Two weeks after selection almost all Akata cells were dead, but a
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small percentage of Raji cells began proliferating. About ten fold more Raji than Akata cells
survived the selection. Of note, control Raji cells with a high resistance to G418 behaved
unusually. About 80% of Raji cells in our control samples existed as single cells
distributed evenly in their suspension medium. The other 20% existed in clumps with the
appearance of a bunch of grapes. The G418 resistant cells were all in clumps. It was
possible to separate the cells by pipetting the suspension fluid up and down numerous
times, but within 24 hours they would re-aggregate and float to the bottom of the flask.

4.5 Expression and Localization of GFP-Rad52 in non-adherent

On day 9 post-selection the cells were imaged using fluoroscopic
microscopy. Although only a small percentage (approximately 0.25%) of Akata cells
expressed a clear signal, the GFP was easily visualized and localized to a round structure
presumed to be the nucleus (Fig. 8). These images are consistent with both concentration in
the nucleoli (figure on the right) and exclusion from the nucleoli (image in the center) (Fig.
8). The GFP signal in Raji was very faint and present in a small number of cells (not
shown).

Expression of GFP-Rad52 in Akata Cells

Fig. 8

Fig. 8

GFP-Rad52 expression in Akata cells. The signal appears to be confined to the nucleus.

5. DISCUSSION

5.1 Efficiency of Transduction

The retrovirus vector containing GFP-Rad52 which we used to infect human cells
has been shown to be effective in transducing murine cells. We have shown that the same
construct is capable of infecting human cells, and have generated transductants of four
human cell lines which stably express GFP-Rad52: F1T1080, FleLa, Saos-2 and Akata. We
saw a variety of degrees and patterns of expression of GFP-Rad52 in the different
transductants. The variety was expected but the reasons behind it are unclear. Why was the
efficiency so much lower than in murine cells? The answer may lie in the vector we used:
LXSN, with a MoMLV derived LTR promoter region.
Several studies have compared gene expression in transduced cells with different
vectors. Although the genes used in these studies were not Rad52, the results are still
significant. One study comparing LXSN to a MFG, another LTR-based retroviral vector,
showed that LXSN demonstrated only 1-2% of the efficiency of the MFG vector in human
cells, and 5-10% of the MFG efficiency in mouse cells. Viral titres using MFG were
higher than in MoMLV derived vectors in all cell lines (35).
Even when rates of transduction are the same, other vectors may produce higher
rates of gene expression. The MNDeGFPSN vector has similar transduction rates to LXSN
but 4-8 fold higher expression (36). Although MoMLV vectors are widely used in gene
therapy experiments, both the MNDeGFPSN and the MFG vectors are more efficient.
Vector inefficiency, therefore, may explain some of the difference in expression between
human and murine cells in our experiment.
Regardless of the nature of the vector, it is likely that the structure and function of
different cells as well as their individual innate resistance to G418 accounted for some of the
variance in expression of GFP-Rad52 that we observed. Future studies looking at the
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localization of Rad52 in response to DNA damage, during the cell cycle, and in
lymphocytes in response to activation of immunoglobulin switch recombination, could help
clarify the role of the cells' individual phenotype in Rad52 expression. It is also possible
that the small degree of variation in the primary structure of human and mouse Rad52
contributes to the observed differences in expression. Future studies using human Rad52
instead of murine Rad52 in human cells may show different results.

5.2 Localization of Signal

Most of the GFP-Rad52 in the cells we observed was localized to the nucleus. The
nuclear signal was either concentrated in the nucleolus or excluded from the nucleolus.
These findings are consistent with previously described localization of GFP-Rad52 in
mouse cells (29). In mouse cells the signal is concentrated in the nucleoli during both S
phase, during rDNA synthesis, and G0, when the cell is at rest (29). The presence of GFPRad52 in the nucleolus suggests that mammalian Rad52 is involved in rDNA recombination
as it is in yeast, but we can not rule out that Rad52 is sequestered in the nucleolus for other
reasons. As in previous studies (29), cells showing nuclear localization with exclusion
from the nucleolus may be in G, phase. Future studies examining the localization of GFPRad52 in human cells during the cell cycle will help answer these questions.
Interestingly, the signal in Akata cells did not appear to be clearly associated with the
nucleolus. This is significant because previous studies with activated primary murine
lymphocytes showed GFP-Rad52 concentrated in the nucleolus in the great majority of
cells (29). Conclusions from our study are limited, however, due to the low number of
Akata cells expressing the protein and the weakness of the signal.
We are still left searching for an explanation for the cytoplasmic localization of
GFP-Rad52 in a majority of Saos-2 and HeLa cells. Is there something about these cells
that causes the nucleus to deny access to the GFP-Rad52 protein? Do the Saos-2 cells, as
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hypothesized in the introduction, fail to recruit the protein to the nucleus since they are blind
to their double strand DNA defects?
The question arises of whether this cytoplamic distribution is related to cell
pathology or death. Although the Saos-2 cells which showed this distribution appeared to
be growing normally, they are inherently unhealthy. The HeLa cells with this expression
pattern may have been dying. HeLa cells are normally diamond shaped and adhere to the
bottom of the culture plate. When they become confluent the cells grow on top of eachother
in a spherical shape. The cells we observed with cytoplasmic Rad52 distribution were
round in shape and in areas of over-confluence. Perhaps a sick or dying cell banishes
Rad52 from the nucleus because it has given up on DNA repair. It would be of great
interest to see if these finding hold true in future studies.

5.3 Conclusions
In summary we have created lines of Akata, HeLa, and HT1080 cells which stably
express GFP-Rad52. Although there was expression in Saos-2 and Raji cells, it was not
sufficient to allow for evaluation. Of note, the localization in human cells was consistent
with that in murine cells except for the cytoplasmic localization in HeLa and Saos-2-cells.
Since in vitro studies show the same biochemical properties of Rad52 for yeast and
mammalian DNA, how do we explain the difference in genetic results, which appear to show
that deletion of mammalian Rad52 has little effect? As stated in the Introduction, it may be
that mammalian cells rely more on Ku or Rad52 homologues. Still, if any possibility exists
that Rad52 plays an important role in DNA repair or in tumorigenesis in mammals, it is
essential to understand the function of this protein in humans. Even if the absence of
Rad52 is proven not to be detrimental to human cell function and life-span, the question
remains as to what benefit may come from its over-expression. Since GFP-Rad52 confers
enhanced survival to cells damaged with ionizing radiation (Liu and Maizels, submitted),
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could there be a role for gene therapy with Rad52 in patients who have undergone healthytissue damage after radiation therapy? Does Rad52 have a role in repairing damage to the
DNA of telomeres and therefore in keeping the aging process in check (37)? These
questions raise exciting possibilities and demand additional research.
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